Dihydroartemisinin (DHA) has been globally recognized for its efficacy and safety in the
clinical treatment of malaria for decades. Recently, it has been found that DHA inhibits …

Malaria reflects not only a state of immune activation, but also a state of general immune
defect or immunosuppression, of complex etiology that can last longer than the actual …

The dynamics of CD4+ T cell memory development remain to be examined at genome
scale. In malaria-endemic regions, antimalarial chemoprevention protects long after its …

Dengue virus (DENV) can cause diseases ranging from dengue fever (DF) to more severe
dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Whether antiviral T cells …

Cytokine-producing CD4 T cells have important roles in immunity against Plasmodium
falciparum (Pf) malaria. However, the factors influencing functional differentiation of Pf …

Background It has been shown that dihydroartemisinin (DHA) is effective in the treatment of
malaria. Recently studies have demonstrated that DHA also regulates tumor cell growth …

Malaria remains a significant cause of morbidity and mortality worldwide, particularly in
infants and children. Some studies have reported that exposure to malaria antigens in utero …

Background: Psoriasis is a T help 17 (Th17) cell-mediated chronic inflammatory skin
disease. Recent studies have shown that dihydroartemisinin (DHA) can significantly reduce …

CD4+ Th cell differentiation is crucial for protecting against blood-stage Plasmodium
parasites, the causative agents of malaria. It has been known for decades that more than …

Background A mother's infection with placental malaria (PM) can affect her child's
susceptibility to malaria, although the mechanism remains unclear. The fetus acquires a …